The RightAI platform aims to assist clinicians in selecting the right patients for clinical trials and make precise treatment ...

A partial hold was placed on the trial after results showed variance between squamous and non-squamous NSCLC patient ...

Nurix Therapeutics has reported positive clinical data from its ongoing Phase Ia/Ib trial of NX-5948 for Waldenstrom's ...

Vabysmo is the first drug of its kind to receive approval for diabetic macular oedema treatment. Credit: Prostock-studio / ...

RZ-402 has the potential to treat or prevent DME, and influence both clinical practice and patient burden experienced by DME ...

The Phase IIa study (NCT06235905) met its primary endpoint – showing a clinically meaningful improvement of -6.1 on the ...

Clinical stage biopharma Kezar Life Sciences is discontinuing its lupus nephritis (LN) clinical programme following the death ...

Genprex received approval to proceed to the highest dose in the Phase I Acclaim-3 trial of Reqorsa for ES-small cell lung ...

Integrated clinical trial network Eximia Research has expanded into Iowa, US, with the acquisition of Integrated Clinical ...

Amylyx Pharmaceuticals has announced positive results from the trial, indicating sustained improvements with AMX0035 in ...

Response Pharmaceuticals has initiated subject enrolment for a Phase II trial of its drug candidate RDX-002, designed to ...

Innovent Biologics has reported that its trial of picankibart (IBI112) in Chinese patients with ulcerative colitis met the ...